Thyrocare Technologies Limited (THYROCARE) Share Analysis
NSE · Healthcare · Hospital & Healthcare Services
Thyrocare Technologies Limited (NSE: THYROCARE) is an Indian listed company in the Hospital & Healthcare Services sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹556.00, market capitalisation ₹8,846 Cr, P/E 49, ROE 28.4%.
Get the AI verdict on THYROCARE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
THYROCARE price and valuation
- Share price
- ₹556.00
- Market cap
- ₹8,846 Cr
- P/E ratio
- 49
- P/B ratio
- 15.11
- EPS
- ₹11.08
- Book value per share
- ₹36.80
- Dividend yield
- 1.68%
THYROCARE profitability and growth
- ROE
- 28.4%
- ROCE
- 35.4%
- Debt to equity
- 0.09
- Revenue growth (3 yr)
- 16%
- Revenue growth (5 yr)
- 11%
- Profit growth (3 yr)
- 36%
- Profit growth (5 yr)
- 8%
THYROCARE 52-week range
- 52-week high
- ₹662.00
- 52-week low
- ₹342.55
- Face value
- ₹10.00
THYROCARE shareholding pattern
- Promoters
- 60.92%
- FIIs
- 5.43%
- DIIs
- 20.92%
- Public
- 12.71%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.